An open-label safety and tolerability clinical trial of PST-611 in dry age-related macular degeneration.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519025-37-00

Acronym

PST-611-CT1

Enrollment

Registered

2025-05-12

Start date

2025-06-19

Completion date

Unknown

Last updated

2025-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry age-related macular degeneration.

None listed

Sex/Gender

All

Age

18 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026